These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3542653)

  • 1. Adverse effects of insulin antibodies on postprandial plasma glucose and insulin profiles in diabetic patients without immune insulin resistance. Implications for intensive insulin regimens.
    Van Haeften TW; Heiling VJ; Gerich JE
    Diabetes; 1987 Mar; 36(3):305-9. PubMed ID: 3542653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial blood glucose response to exercise in type I diabetes: comparison between pump and injection therapy.
    Koivisto VA; Tronier B
    Diabetes Care; 1983; 6(5):436-40. PubMed ID: 6400702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects.
    Kang S; Creagh FM; Peters JR; Brange J; Vølund A; Owens DR
    Diabetes Care; 1991 Jul; 14(7):571-7. PubMed ID: 1914797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
    McMahon M; Marsh HM; Rizza RA
    Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies.
    Olsson PO
    Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
    Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
    Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy.
    Pehling G; Tessari P; Gerich JE; Haymond MW; Service FJ; Rizza RA
    J Clin Invest; 1984 Sep; 74(3):985-91. PubMed ID: 6381541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus.
    Perriello G; De Feo P; Torlone E; Calcinaro F; Ventura MM; Basta G; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    N Engl J Med; 1988 Nov; 319(19):1233-9. PubMed ID: 3054544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthetic human insulin improves postprandial glucose excursions in type I diabetics.
    Gulan M; Gottesman IS; Zinman B
    Ann Intern Med; 1987 Oct; 107(4):506-9. PubMed ID: 3307584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans.
    Liddle RA; Rushakoff RJ; Morita ET; Beccaria L; Carter JD; Goldfine ID
    J Clin Invest; 1988 Jun; 81(6):1675-81. PubMed ID: 3290250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus.
    Spinas GA; Bock A; Keller U
    Diabetes Care; 1985; 8(5):429-35. PubMed ID: 2865093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of twice daily subcutaneous administration of a long-acting somatostatin analog on 24-hour plasma glucose profiles in patients with insulin-dependent diabetes mellitus.
    Dimitriadis G; Gerich J
    Horm Metab Res; 1985 Oct; 17(10):510-1. PubMed ID: 2866155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus.
    Bolli GB; Dimitriadis GD; Pehling GB; Baker BA; Haymond MW; Cryer PE; Gerich JE
    N Engl J Med; 1984 Jun; 310(26):1706-11. PubMed ID: 6374455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free insulin profiles in insulin-dependent diabetics treated with one or two insulin injections per day.
    Olsson PO; Arnqvist H; von Schenck H
    Acta Med Scand; 1986; 220(2):133-41. PubMed ID: 3535391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of insulin antibody levels on the plasma profiles and action of subcutaneously injected human and bovine short acting insulins.
    Francis AJ; Hanning I; Alberti KG
    Diabetologia; 1985 Jun; 28(6):330-4. PubMed ID: 3899818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.
    Linnebjerg H; Kothare PA; Skrivanek Z; de la Peña A; Atkins M; Ernest CS; Trautmann ME
    Diabet Med; 2006 Mar; 23(3):240-5. PubMed ID: 16492205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.